Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check4 days agoChange DetectedThe footer revision notice was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now includes a Locations section with North Holland (Amsterdam UMC, location VUmc); the old North Holland Locations header was removed and the footer HHS Vulnerability Disclosure link was removed, with revision tag updated to v3.3.3.SummaryDifference0.2%

- Check54 days agoChange DetectedThe additions include an automated PubMed publications note and a revision tag (Revision: v3.3.2). The deletions remove the older PubMed note and the previous revision tag (Revision: v3.2.0).SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the funding-status notice that warned about potential delays in updating information due to government funding. This does not modify the study details, eligibility criteria, or outcomes listed on the page.SummaryDifference0.3%

- Check75 days agoChange DetectedThe new screenshot shows minor layout and styling tweaks that do not modify study content, eligibility criteria, locations, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange DetectedMajor change: new version v3.2.0 plus a government operating status notice; removal of v3.1.0 indicates the update to the latest release.SummaryDifference2%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.